학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 8건 | 목록 1~10
Academic Journal
Moure AL; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Narula GSorrentino F; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Bojang ATsui CKMSao Emani CPorras-De Francisco E; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Díaz B; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Rebollo-López MJ; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Torres-Gómez PA; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; López-Román EM; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Camino I; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Casado Castro P; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Guijarro López L; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Ortega F; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Ballell L; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Barros-Aguirre D; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Remuiñán Blanco M; Diseases of the Developing World (DDW), Global Health Catalyst, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Av-Gay Y
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Cunningham F; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Esquivias J; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Fernández-Menéndez R; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Pérez A; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Guardia A; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Escribano J; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Rivero C; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Vimal M; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.; Cacho M; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; de Dios-Antón P; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Martínez-Martínez MS; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Jiménez E; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Huertas Valentín L; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Rebollo-López MJ; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; López-Román EM; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Sousa-Morcuende V; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Rullas J; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Neu M; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.; Chung CW; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.; Bates RH; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.
Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE
Academic Journal
Wilson CR; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Gessner RK; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Moosa A; SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town , Rondebosch 7701, South Africa.; Seldon R; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Rondebosch 7701, South Africa.; Warner DF; SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town , Rondebosch 7701, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Rondebosch 7701, South Africa.; Mizrahi V; SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town , Rondebosch 7701, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Rondebosch 7701, South Africa.; Soares de Melo C; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Simelane SB; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Nchinda A; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Abay E; Department of Medicine, Division of Clinical Pharmacology, Drug Discovery and Development Centre (H3D), University of Cape Town , Observatory, 7925, South Africa.; Taylor D; Department of Medicine, Division of Clinical Pharmacology, Drug Discovery and Development Centre (H3D), University of Cape Town , Observatory, 7925, South Africa.; Njoroge M; Department of Medicine, Division of Clinical Pharmacology, Drug Discovery and Development Centre (H3D), University of Cape Town , Observatory, 7925, South Africa.; Brunschwig C; Department of Medicine, Division of Clinical Pharmacology, Drug Discovery and Development Centre (H3D), University of Cape Town , Observatory, 7925, South Africa.; Lawrence N; Department of Medicine, Division of Clinical Pharmacology, Drug Discovery and Development Centre (H3D), University of Cape Town , Observatory, 7925, South Africa.; Boshoff HIM; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland 20892, United States.; Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland 20892, United States.; Sirgel FA; DST/NRF Centre of Excellence for Biomedical TB Research, SA MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University , 7505 Tygerberg, South Africa.; van Helden P; DST/NRF Centre of Excellence for Biomedical TB Research, SA MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University , 7505 Tygerberg, South Africa.; Harris CJ; CJH Consultants , Ford Cottage, South Weirs, Brockenhurst, Hampshire SO42 7UQ, U.K.; Gordon R; Strategic Health Innovation Partnerships (SHIP), South African Medical Research Council , Parow Valley, Cape Town, South Africa.; Ghidelli-Disse S; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, Heidelberg 69117, Germany.; Pflaumer H; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, Heidelberg 69117, Germany.; Boesche M; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, Heidelberg 69117, Germany.; Drewes G; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, Heidelberg 69117, Germany.; Sanz O; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Santos G; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Rebollo-Lopez MJ; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Urones B; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Selenski C; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Lafuente-Monasterio MJ; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Axtman M; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Lelièvre J; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Ballell L; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Mueller R; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Street LJ; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Ghorpade SR; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Chibale K; Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town , Rondebosch 7701, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Rondebosch 7701, South Africa.; South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry, University of Cape Town , Rondebosch 7701, South Africa.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Park Y; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health , Bethesda, Maryland 20892-3206, United States.; Pacitto A; Department of Biochemistry, University of Cambridge , Cambridge CB2 1GA, United Kingdom.; Bayliss T; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Cleghorn LA; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Wang Z; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College , New York, New York 10065, United States.; Hartman T; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College , New York, New York 10065, United States.; Arora K; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health , Bethesda, Maryland 20892-3206, United States.; Ioerger TR; Department of Computer Science and Engineering, Texas A&M University , College Station, Texas 77843, United States.; Sacchettini J; Department of Biochemistry & Biophysics, Texas A&M University , College Station, Texas 77843, United States.; Rizzi M; Dipartimento di Scienze del Farmaco, University of Piemonte Orientale , Via Bovio 6, 28100 Novara, Italy.; Donini S; Dipartimento di Scienze del Farmaco, University of Piemonte Orientale , Via Bovio 6, 28100 Novara, Italy.; Blundell TL; Department of Biochemistry, University of Cambridge , Cambridge CB2 1GA, United Kingdom.; Ascher DB; Department of Biochemistry, University of Cambridge , Cambridge CB2 1GA, United Kingdom.; Rhee K; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College , New York, New York 10065, United States.; Breda A; Department of Biochemistry & Biophysics, Texas A&M University , College Station, Texas 77843, United States.; Zhou N; Department of Biochemistry & Biophysics, Texas A&M University , College Station, Texas 77843, United States.; Dartois V; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey , Newark, New Jersey 07103, United States.; Jonnala SR; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health , Bethesda, Maryland 20892-3206, United States.; Via LE; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health , Bethesda, Maryland 20892-3206, United States.; MRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Rondebosch 7700, South Africa.; Mizrahi V; MRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Rondebosch 7700, South Africa.; Epemolu O; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Stojanovski L; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Simeons F; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Osuna-Cabello M; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Ellis L; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; MacKenzie CJ; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Smith AR; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Davis SH; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Murugesan D; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Buchanan KI; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Turner PA; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Huggett M; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Zuccotto F; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Rebollo-Lopez MJ; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Lafuente-Monasterio MJ; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Sanz O; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Diaz GS; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Lelièvre J; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Ballell L; Diseases of the Developing World, GlaxoSmithKline , Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain.; Selenski C; GlaxoSmithKline , 5 Crescent Drive, Philadelphia, Pennsylvania 19112, United States.; Axtman M; GlaxoSmithKline , 5 Crescent Drive, Philadelphia, Pennsylvania 19112, United States.; Ghidelli-Disse S; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, 69117 Heidelberg, Germany.; Pflaumer H; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, 69117 Heidelberg, Germany.; Bösche M; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, 69117 Heidelberg, Germany.; Drewes G; Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline , Meyerhofstrasse 1, 69117 Heidelberg, Germany.; Freiberg GM; AbbVie Molecular Characterization , 1 North Waukegan Road, North Chicago, Illinois 60064, United States.; Kurnick MD; AbbVie Molecular Characterization , 1 North Waukegan Road, North Chicago, Illinois 60064, United States.; Srikumaran M; AbbVie Molecular Characterization , 1 North Waukegan Road, North Chicago, Illinois 60064, United States.; Kempf DJ; AbbVie Molecular Characterization , 1 North Waukegan Road, North Chicago, Illinois 60064, United States.; Green SR; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Ray PC; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Read K; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Wyatt P; Drug Discovery Unit, College of Life Sciences, James Black Centre, University of Dundee , Dundee DD1 5EH, United Kingdom.; Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health , Bethesda, Maryland 20892-3206, United States.; MRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Rondebosch 7700, South Africa.; Boshoff HI; Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health , Bethesda, Maryland 20892-3206, United States.
Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE
Academic Journal
Abrahams KA; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.; Chung CW; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.; Ghidelli-Disse S; Cellzome-a GSK Company, Meyerhofstrasse 1, 69117 Heidelberg, Germany.; Rullas J; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Rebollo-López MJ; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Gurcha SS; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.; Cox JA; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.; Mendoza A; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Jiménez-Navarro E; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Martínez-Martínez MS; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Neu M; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.; Shillings A; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.; Homes P; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.; Argyrou A; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK.; Casanueva R; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Loman NJ; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.; Moynihan PJ; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.; Lelièvre J; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Selenski C; GlaxoSmithKline, 709 Swedeland Road, PO Box 1539, King of Prussia, Pennsylvania 19406-0939, USA.; Axtman M; GlaxoSmithKline, 709 Swedeland Road, PO Box 1539, King of Prussia, Pennsylvania 19406-0939, USA.; Kremer L; Centre National de la Recherche Scientifique FRE 3689, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé, Université de Montpellier, 1919 route de Mende, 34293 Montpellier, France.; INSERM, CPBS, 34293 Montpellier, France.; Bantscheff M; Cellzome-a GSK Company, Meyerhofstrasse 1, 69117 Heidelberg, Germany.; Angulo-Barturen I; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Izquierdo MC; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Cammack NC; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Drewes G; Cellzome-a GSK Company, Meyerhofstrasse 1, 69117 Heidelberg, Germany.; Ballell L; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Barros D; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.; Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.; Bates RH; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Rebollo-Lopez MJ; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Lelièvre J; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Alvarez-Gomez D; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Castro-Pichel J; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Martínez-Jiménez F; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), Barcelona, Spain.; Gene Regulation Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), Barcelona, Spain.; Papadatos G; European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom.; Kumar V; Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.; Colmenarejo G; Centro de Investigación Básica, CSci Computational Chemistry, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Mugumbate G; European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom.; Hurle M; Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.; Barroso V; Centro de Investigación Básica, Platform Technology & Science, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Young RJ; CSC Medicinal Chemistry, Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom.; Martinez-Hoyos M; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; González del Río R; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Bates RH; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Lopez-Roman EM; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Mendoza-Losana A; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Brown JR; Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.; Alvarez-Ruiz E; Centro de Investigación Básica, Platform Technology & Science, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Marti-Renom MA; Genome Biology Group, Centre Nacional d'Anàlisi Genòmica (CNAG), Barcelona, Spain.; Gene Regulation Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Overington JP; European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom.; Cammack N; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Ballell L; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.; Barros-Aguire D; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Ballell L; Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline (GSK), Severo Ochoa 2, Tres Cantos, Madrid, Spain. lluis.p.ballell@gsk.com; Bates RHYoung RJAlvarez-Gomez DAlvarez-Ruiz EBarroso VBlanco DCrespo BEscribano JGonzález RLozano SHuss SSantos-Villarejo AMartín-Plaza JJMendoza ARebollo-Lopez MJRemuiñan-Blanco MLavandera JLPérez-Herran EGamo-Benito FJGarcía-Bustos JFBarros DCastro JPCammack N
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Rebollo-Lopez MJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어